e-ESO Podcasts

143 Episodes

1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

   Published: 2/2/2023
2. Basics of prostate cancer pathology

   Published: 1/26/2023
3. Oligometastaic breast cancer

   Published: 1/19/2023
4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

   Published: 1/12/2023
5. Summary/Review - Reporting Guidelines - CHEERS

   Published: 12/6/2022
6. Role of immunotherapy in head and neck cancer

   Published: 12/1/2022
7. AYAs with cancer: the right to be forgotten

   Published: 11/24/2022
8. Summary/Review - Reporting Guidelines - SQUIRE

   Published: 11/17/2022
9. Male breast cancer

   Published: 11/10/2022
10. Summary/Review - Reporting Guidelines - SRQR

    Published: 11/3/2022
11. Summary/Review - Reporting Guidelines - AGREE

    Published: 10/27/2022
12. Breast Cancer: Frequently Asked Questions and Answers

    Published: 10/20/2022
13. The role of Medical Physicist in Oncology

    Published: 10/13/2022
14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Published: 10/6/2022
15. Parp inhibitors in ovarian cancer

    Published: 9/29/2022
16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Published: 9/22/2022
17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Published: 9/15/2022
18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Published: 9/8/2022
19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Published: 9/1/2022
20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Published: 7/27/2022